Nectar Lifescience Ltd share price logo

Nectar Lifescience Ltd Share Price

(NECLIFE)

₹22.952.8%

as on 04:01PM, 28 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Nectar Lifescience Ltd Performance

  • Day's Low

    Day's High

    ₹22.75
    Day's Price Range
    ₹24.54
  • 52 Week's Low

    52 Week's High

    ₹22.1
    52-Week Price Range
    ₹56.5
1 Month Return-10.04 %
3 Month Return-39.95 %
1 Year Return-32.99 %
Previous Close₹23.61
Open₹24.00
Volume23.41L
Upper Circuit₹24.79
Lower Circuit₹22.42
Market Cap₹514.68Cr

Nectar Lifescience Ltd Fundamentals

P/E Ratio

30.2

PEG Ratio

75.49

Market Cap

₹514.68 Cr

P/B Ratio

0.63

EPS

0.22

Dividend Yield

0

Sector

Pharmaceuticals

ROE

0.47

Key events for Nectar Lifescience Ltd

  • Nectar Lifesciences Addresses EU Inspection Observations - 10 Mar, 2025

    Nectar Lifesciences Ltd. faced seven observations, including four critical ones, during a recent EU regulatory inspection. The company is preparing a Corrective Action and Preventive Action report and anticipates a re-inspection, which could lead to EuGMP approval.

Insights on Nectar Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 0.59 Cr → 7.84 Cr (in ₹), with an average increase of 51.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 359.85 Cr → 455.56 Cr (in ₹), with an average increase of 11.0% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 32.54% to 54.72% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 44.35% to 44.53% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.8% return, outperforming this stock by 135.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 61.9% return, outperforming this stock by 94.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.57% to 0.73% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NECLIFE stock has moved down by -10.0%

Nectar Lifescience Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹452.16Cr (-)₹439.85Cr (↓2.72%)₹358.85Cr (↓18.42%)₹427.88Cr (↑19.24%)₹454.33Cr (↑6.18%)
Net Income₹1.57Cr (-)₹0.59Cr (↓62.42%)₹2.97Cr (↑403.39%)₹5.60Cr (↑88.55%)₹7.84Cr (↑40.00%)
Net Profit Margin0.35% (-)0.13% (↓62.86%)0.83% (↑538.46%)1.31% (↑57.83%)1.73% (↑32.06%)
Value in ₹ crore
Details2021202220232024
Total Assets₹2,514.45Cr (-)₹2,520.35Cr (↑0.23%)₹2,323.80Cr (↓7.80%)₹2,324.02Cr (↑0.01%)
Total Liabilities₹1,453.71Cr (-)₹1,433.48Cr (↓1.39%)₹1,259.20Cr (↓12.16%)₹1,254.76Cr (↓0.35%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹285.65Cr (-)₹21.33Cr (↓92.53%)₹95.04Cr (↑345.57%)₹133.37Cr (↑40.33%)₹224.69Cr (↑68.47%)

Nectar Lifescience Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
44.53%
0.40
Foreign Institutions
0.73%
-71.56
Mutual Funds
0%
0.00
Retail Investors
54.72%
68.14
Others
0.02%
-99.90

Nectar Lifescience Ltd Key Indicators

Details20202021202220232024
Return On Equity %2.68-4.351.48-5.850.47
Details20202021202220232024
Return On Assets %1.2-2.910.99-1.040.22
Details20202021202220232024
Book Value Per Share (₹)50.6647.3648.5147.4747.68
Details20202021202220232024
Earning Per Share (₹)1.42-3.271.12-1.080.22

Nectar Lifescience Ltd Valuation

Nectar Lifescience Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-284.58x)

December 21, 2023

Today (30.20x)

March 28, 2025

Industry (53.18x)

March 28, 2025

Highest (403.33x)

August 26, 2020

LowHigh

Nectar Lifescience Ltd Earnings and Dividends

  • Nectar Lifescience Ltd Earnings Results

    Nectar Lifescience Ltd’s net profit jumped 399.36% since last year same period to ₹7.84Cr in the Q3 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 40% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Nectar Lifescience Ltd Dividends July,2020

    In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.22%.

    Read More about Dividends

Nectar Lifescience Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Nectar Lifescience Ltd is currently in a Bearish trading position according to technical analysis indicators.

Nectar Lifescience Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹514.68 Cr28.32%0.69₹5 Cr₹1,684 Cr
NA₹22.46 Cr78.35%0.50NANA
NA₹1,923.52 Cr980.26%0.54₹36 Cr₹295 Cr
NA₹901.74 Cr648.5%0.65₹23 Cr₹307 Cr
NA₹117.60 Cr31.24%0.72-₹10 Cr₹368 Cr

About Nectar Lifescience Ltd

Nectar Lifesciences Ltd (NLL or NECLIFE) is a globally acclaimed integrated pharmaceutical organization engaged in the manufacture and supply of high quality pharmaceutical products. With a vast network of production sites spread across three Indian states of Punjab, Himachal Pradesh, and Jammu, the organization provides top-notch active pharmaceutical ingredients (API), finished dosage forms, phytochemicals, and hard gelatin capsules to customers in over 90 countries across the world. In addition to manufacturing and marketing cephalosporins and phytochemicals, NECLIFE is also into contract manufacturing of APIs. Established in 1995, the organization has seen a number of expansions, the most recent being in 2019 when they established a unit in Portugal to take over marketing activities from the UK-based wing. They have also launched two new innovative products in the form of menthol capsules and pearl capsules. Focussing on providing quality products, NECLIFE has obtained approval from the Japanese MOH and is well-poised to continue its phenomenal rise in the global pharmaceuticals market.

Revenue: ₹454.33Cr as on December 2024 (Q4 24)
Net Profit: ₹7.84Cr as on December 2024 (Q4 24)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
OrganisationNectar Lifescience Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Nectar Lifescience Ltd

What is Nectar Lifescience Ltd price today?

Nectar Lifescience Ltd share price today stands at ₹22.95, Open: ₹24, Previous Close: ₹23.61, High: ₹24.54, Low: ₹22.75, 52 Week High: ₹56.5, 52 Week Low: ₹22.1.

How to Buy Nectar Lifescience Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Nectar Lifescience Ltd shares

What are today's traded volumes of Nectar Lifescience Ltd?

Today's traded volume of Nectar Lifescience Ltd(NECLIFE) is 23.41L.

What is today's market capitalisation of Nectar Lifescience Ltd?

Today's market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹514.68Cr.

What is the 52 Week High and Low Range of Nectar Lifescience Ltd?

Nectar Lifescience Ltd (NECLIFE)
Price
52 Week High
₹56.5
52 Week Low
₹22.1

How much percentage Nectar Lifescience Ltd is down from its 52 Week High?

Nectar Lifescience Ltd (NECLIFE) share price is ₹22.95. It is down -59.38% from its 52 Week High price of ₹56.5

How much percentage Nectar Lifescience Ltd is up from its 52 Week low?

Nectar Lifescience Ltd (NECLIFE) share price is ₹22.95. It is up 3.85% from its 52 Week Low price of ₹22.1